 |
Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference
Feb 21, 2012
|
8.8 KB |
|
| |
CAMBRIDGE, Mass., Feb. 21, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the Citi Global Healthcare Conference on February 27, 2012 at 3:00 p.m. ET at the Waldorf Astoria in New York City.
The live and archived webcast of the company presentatio...
|
|
Idenix to Host Conference Call Discussing Fourth Quarter and Year End 2011 Financial Results and Pipeline Update
Feb 16, 2012
|
9.2 KB |
|
| |
CAMBRIDGE, Mass., Feb. 16, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) announced today that it will report its financial results for the fourth quarter and year end 2011 on Thursday, February 23, 2012 after the U.S. financial markets close.
Idenix management will host a conference call at 4:30 p.m. ET on Thursday, Februa...
|
|
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 7, 2012
|
8.9 KB |
|
| |
CAMBRIDGE, Mass., Feb. 7, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the 14th Annual BIO CEO & Investor Conference on February 14, 2012 at 10:00 a.m. ET at the Waldorf Astoria, New York City and at the Leerink Swann 2012 Global Healthcare Conference o...
|
|
Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184
Feb 3, 2012
|
13.5 KB |
|
| |
CAMBRIDGE, Mass., Feb. 3, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the partial clinical hold on IDX1...
|
|
Idenix Reports Advancement of HCV Development Pipeline
Jan 9, 2012
|
13.5 KB |
|
| |
CAMBRIDGE, Mass., Jan. 9, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the advancement of its hepatitis C virus (HCV) development pipeline.
IDX719: NS5A ProgramIdenix announced today th...
|
|
Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
Jan 9, 2012
|
14.6 KB |
|
| |
CAMBRIDGE, Mass., Jan. 9, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of...
|
|
Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Jan 3, 2012
|
8.8 KB |
|
| |
CAMBRIDGE, Mass., Jan. 3, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 at 2:00 p.m. PST at the Westin St. Francis in San Francisco.
The live and archived webcast of the compa...
|
|
Idenix Pharmaceuticals Prices Public Offering of Common Stock
Nov 16, 2011
|
8.9 KB |
|
| |
CAMBRIDGE, Mass., Nov. 16, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 9,393,416 shares of its common stock at a public offering p...
|
|
Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
Nov 15, 2011
|
8.9 KB |
|
| |
CAMBRIDGE, Mass., Nov. 15, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has commenced an underwritten registered public offering of shares of its common stock. All of these shares are ...
|
|
Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
Nov 2, 2011
|
22.4 KB |
|
| |
CAMBRIDGE, Mass., Nov. 2, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the third quarter and nine months ended September 30, 2011. At September 30, 2011, Idenix'...
|
|
Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD)
Oct 26, 2011
|
10.4 KB |
|
| |
CAMBRIDGE, Mass., Oct. 26, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) announced today that it will report its financial results for the third quarter of 2011 on Wednesday, November 2, 2011 after U.S. financial markets close.
Idenix management will host a conference call at 4:30 p.m. ET on Wednesday, November 2, 2011 to disc...
|
|
Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Sep 20, 2011
|
8.7 KB |
|
| |
CAMBRIDGE, Mass., Sept. 20, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the JMP Securities Healthcare Conference on September 27, 2011 at 1:30 p.m. ET at the St. Regis Hote...
|
|
Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Sep 14, 2011
|
8.6 KB |
|
| |
CAMBRIDGE, Mass., Sept. 14, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX - News), announced today that Idenix management will present a corporate overview at the UBS Global Life Sciences Conference on September 21, 2011 at 2:00 p.m. ET at the Grand Hyatt, New York City.
The live and archived webcast of the comp...
|
|
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Sep 6, 2011
|
8.9 KB |
|
| |
CAMBRIDGE, Mass., Sept. 6, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the Morgan Stanley Global Healthcare Conference on September 13 at 8:35 a.m. ET at the Grand Hyatt, ...
|
|
Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
Aug 31, 2011
|
9.0 KB |
|
| |
CAMBRIDGE, Mass., Aug. 31, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will participate in a panel discussion at Citi's 6th Annual Biotech Day on September 7, 2011 at 10:00 a.m. ET at the Ritz Carlton, ...
|
|
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2011 Financial Results and Provides Pipeline Update
Aug 8, 2011
|
20.9 KB |
|
| |
CAMBRIDGE, Mass., Aug. 8, 2011 /PRNewswire via COMTEX/ --
Lead nucleotide polymerase inhibitor IDX184 advancing clinically - The Company has initiated dosing of IDX184 in combination with pegylated interferon and ribavirin (Peg-IFN/RBV) in a Phase IIb hepatitis C virus (HCV) trial...
|
|
Idenix to Host Conference Call Discussing Second Quarter and Six Month 2011 Financial Results
Jul 21, 2011
|
9.4 KB |
|
| |
CAMBRIDGE, Mass., July 21, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that it will report its financial results for the second quarter of 2011 on Monday, August 8, 2011 after U.S. financial markets close.
Idenix management will host a conference call ...
|
|
Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
May 26, 2011
|
8.7 KB |
|
| |
CAMBRIDGE, Mass., May 26, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the Jefferies 2011 Global Healthcare Conference on June 9, 2011 at 4:00 p.m. ET in ...
|
|
Idenix Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
May 3, 2011
|
8.7 KB |
|
| |
CAMBRIDGE, Mass., May 3, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the Bank of America Merrill Lynch 2011 Health Care Conference on May 10, 2011 at 1:40 p.m. PT at the Wy...
|
|
Idenix Pharmaceuticals Reports First Quarter 2011 Financial Results
Apr 27, 2011
|
16.7 KB |
|
| |
CAMBRIDGE, Mass., April 27, 2011 /PRNewswire via COMTEX/ --Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the first quarter of 2011. At March 31, 2011...
|
|
|
shareholder briefcase
investor kit
email alerts
download library
news feeds
Email Page
Print Page
Share this page
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz